SHC Overview

Sotera Health Company is a global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. The Company’s segments include Sterigenics, Nordion and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. Nordion business is a global provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.

Wall Street analysts forecast SHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SHC is20.42 USD with a low forecast of 16.00 USD and a high forecast of 24.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Sotera Health Co revenue for the last quarter amounts to 303.44M USD, increased 4.56

Sotera Health Co. EPS for the last quarter amounts to 0.12 USD, increased 200.00

Sotera Health Co (SHC) has 3000 emplpoyees as of March 31 2026.

Today SHC has the market capitalization of 3.77B USD.